(IN BRIEF) Basilea Pharmaceutica has entered into a strategic collaboration with Prokaryotics to develop a first-in-class broad-spectrum antifungal therapy targeting severe invasive fungal infections. The partnership focuses on novel compounds with a new mode of action aimed at pathogens such … Read the full press release →
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Pharma & Biotech, Science, Switzerland, Technology
Tagged anti-infective research, antifungal drug development, Aspergillus, Basilea Partners with Prokaryotics to Develop Novel Broad-Spectrum Antifungal Therapy, Basilea Pharmaceutica, biopharmaceutical collaboration, Candida, clinical development, first in class antifungal, global licensing agreement, invasive fungal infections, Laurenz Kellenberger, novel mode of action, Prokaryotics, rare molds, Terry Roemer
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Load more...
